{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:07:43Z","timestamp":1788782863300,"version":"build-2803163510"},"reference-count":49,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["09150172010035"],"award-info":[{"award-number":["09150172010035"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","award":["BS174"],"award-info":[{"award-number":["BS174"]}],"id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Horizon 2020 European Commission","doi-asserted-by":"publisher","award":["101075876"],"award-info":[{"award-number":["101075876"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In our effort to design an effective ultralow-dose attenuated whole sporozoite (SPZ) vaccine, we explored the use of chemical adjuvants to increase the immunogenicity of sporozoites. Critical to the potency of attenuated sporozoites is their ability to migrate to and infect the liver. We thus used an in vivo mouse challenge model to compare the effects of external and internal chemical modifications to sporozoites. We loaded sporozoites with CL307 using two strategies: a supramolecular surface modification adjuvant system (SPZ-SAS(CL307)) and a mitochondrial membrane potential system (SPZ-MMP(CL307)). SPZ-SAS(CL307) contained 200 times more CL307 as compared to SPZ-MMP(CL307). However, SPZ-SAS(CL307) could not establish a liver infection after intravenous injection (25\u202f000 sporozoites), suggesting loss of function of the sporozoites. On the contrary, SPZ-MMP(CL307) could establish an equivalent liver infection to the control already at a dose of 5000 sporozoites. When the immunized mice were challenged, SPZ-MMP(CL307) equaled the protective efficacy of control sporozoites. Our findings indicate that the MMP system can be used to chemically augment live cells, such as sporozoites, with adjuvants without negatively affecting their infectivity and protective efficacy in vivo. For malaria, further testing of different types of adjuvants at different concentrations is needed to ultimately develop vaccines with increased potency. However, in essence, this platform provides a proof-of-concept for a Trojan horse adjuvanting or drug loading concept for any whole-cell vaccine or therapy, within the infectious diseases space or beyond in oncological applications.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00575","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:25:10Z","timestamp":1787919910000},"page":"4719-4728","source":"Crossref","is-referenced-by-count":0,"title":["The Road toward a Trojan Horse Malaria Vaccine: Chemical\nAugmentation of Live Sporozoites without Affecting Their Viability"],"prefix":"10.1021","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3054-7472","authenticated-orcid":true,"given":"Chanel Mile\u0300ne","family":"Naar","sequence":"first","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333ZA"]},{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roos","family":"van Schuijlenburg","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"van Meerbeek","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Chevalley-Maurel","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili A.","family":"Zigo\u0301","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Franke-Fayard","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-4025","authenticated-orcid":true,"given":"Fijs W. B.","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meta","family":"Roestenberg","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,23]]},"reference":[{"issue":"2","key":"2026090707075800400_cit1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology:\nfrom basic principles to new\ndevelopments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nature Reviews Immunology."},{"key":"2026090707075800400_cit2","volume-title":"World Malaria Report\n2024: Addressing Inequity in the Global Malaria Response","author":"WHO.","year":"2024"},{"issue":"20","key":"2026090707075800400_cit3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1056\/NEJMoa2313892","article-title":"Safety and Efficacy\nof Immunization with a Late-Liver-Stage Attenuated Malaria Parasite","volume":"391","author":"Lamers","year":"2024","journal-title":"N Engl J. Med."},{"issue":"1","key":"2026090707075800400_cit4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41591-024-03347-2","article-title":"Single immunization\nwith genetically attenuated Pf\u0394mei2 (GA2) parasites by mosquito\nbite in controlled human malaria infection: a placebo-controlled randomized\ntrial","volume":"31","author":"Roozen","year":"2025","journal-title":"Nat. Med."},{"issue":"1","key":"2026090707075800400_cit5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12936-025-05299-5","article-title":"Safety,\ntolerability and immunogenicity of a condensed,\nmulti-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium\nfalciparum malaria infection","volume":"24","author":"Berry","year":"2025","journal-title":"Malar J."},{"issue":"1","key":"2026090707075800400_cit6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4161\/hv.6.1.10396","article-title":"Development of a metabolically active, non-replicating\nsporozoite vaccine to prevent Plasmodium falciparum malaria","volume":"6","author":"Hoffman","year":"2010","journal-title":"Human Vaccines."},{"issue":"7940","key":"2026090707075800400_cit7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41586-022-05466-7","article-title":"In vitro\nproduction of infectious Plasmodium falciparum sporozoites","volume":"612","author":"Eappen","year":"2022","journal-title":"Nature."},{"key":"2026090707075800400_cit8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1091961","article-title":"Host-parasite interactions\nduring Plasmodium infection: Implications for immunotherapies","volume":"13","author":"Chandley","year":"2023","journal-title":"Front Immunol."},{"issue":"1","key":"2026090707075800400_cit9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.intimp.2014.02.033","article-title":"Systemic immunotoxicity\nreactions induced by adjuvanted vaccines","volume":"20","author":"Batista-Duharte","year":"2014","journal-title":"International\nImmunopharmacology."},{"issue":"12","key":"2026090707075800400_cit10","doi-asserted-by":"publisher","first-page":"7676","DOI":"10.4049\/jimmunol.174.12.7676","article-title":"Immunization\nwith HIV-1 Gag protein conjugated to a TLR7\/8 agonist results in the\ngeneration of HIV-1 Gag-specific Th1 and CD8+ T cell responses","volume":"174","author":"Wille-Reece","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"2026090707075800400_cit11","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1021\/acsabm.0c01619","article-title":"Chemical Cell Surface\nModification and Analysis of\nNanoparticle-Modified Living Cells","volume":"4","author":"Thomsen","year":"2021","journal-title":"ACS Applied\nBio Materials."},{"issue":"46","key":"2026090707075800400_cit12","doi-asserted-by":"publisher","first-page":"13325","DOI":"10.1039\/D3SC04597H","article-title":"Advancing cell surface\nmodification in mammalian cells with synthetic molecules","volume":"14","author":"Yang","year":"2023","journal-title":"Chemical Science."},{"issue":"9","key":"2026090707075800400_cit13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s44222-024-00198-x","article-title":"Engineering cells for\ntherapy and diagnosis","volume":"2","author":"Li","year":"2024","journal-title":"Nature Reviews Bioengineering."},{"issue":"1","key":"2026090707075800400_cit14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/19336918.2022.2055520","article-title":"Unravelling\ncell migration: defining movement from the cell surface","volume":"16","author":"Merino-Casallo","year":"2022","journal-title":"Cell Adh Migr."},{"issue":"1","key":"2026090707075800400_cit15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.npe.2019.12.003","article-title":"Recent advances in\nmicro\/nanoscale intracellular delivery","volume":"3","author":"Sun","year":"2020","journal-title":"Nanotechnology\nand Precision Engineering."},{"key":"2026090707075800400_cit16","doi-asserted-by":"publisher","first-page":"1204606","DOI":"10.3389\/fimmu.2023.1204606","article-title":"Chemically augmented\nmalaria sporozoites display an altered immunogenic profile","volume":"14","author":"Duszenko","year":"2023","journal-title":"Frontiers in Immunology."},{"issue":"3","key":"2026090707075800400_cit17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41563-022-01464-2","article-title":"A TLR7-nanoparticle adjuvant promotes a broad immune\nresponse against\nheterologous strains of influenza and SARS-CoV-2","volume":"22","author":"Yin","year":"2023","journal-title":"Nat. Mater."},{"issue":"6149","key":"2026090707075800400_cit18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/330664a0","article-title":"Gamma interferon, CD8+ T cells and\nantibodies required for immunity to malaria sporozoites","volume":"330","author":"Schofield","year":"1987","journal-title":"Nature."},{"issue":"2","key":"2026090707075800400_cit19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1073\/pnas.85.2.573","article-title":"CD8+ T\ncells (cytotoxic\/suppressors) are required for protection in mice\nimmunized with malaria sporozoites","volume":"85","author":"Weiss","year":"1988","journal-title":"Proc. Natl.\nAcad. Sci. U. S. A."},{"issue":"5","key":"2026090707075800400_cit20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036508","article-title":"Long term\nprotection after immunization with P. berghei sporozoites correlates\nwith sustained IFN\u03b3 responses of hepatic CD8+ memory T cells","volume":"7","author":"Nganou-Makamdop","year":"2012","journal-title":"PLoS One."},{"key":"2026090707075800400_cit21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118666","article-title":"A Trojan horse:\nChemical boosting of Plasmodium falciparum\nwhole sporozoite vaccine immunogenicity","volume":"192","author":"Naar","year":"2025","journal-title":"Biomed\nPharmacother."},{"issue":"1","key":"2026090707075800400_cit22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41541-022-00558-x","article-title":"Creation and preclinical\nevaluation of genetically attenuated malaria parasites arresting growth\nlate in the liver","volume":"7","author":"Franke-Fayard","year":"2022","journal-title":"npj Vaccines."},{"key":"2026090707075800400_cit23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1204606","article-title":"Chemically augmented\nmalaria sporozoites display an altered immunogenic profile","volume":"14","author":"Duszenko","year":"2023","journal-title":"Front Immunol."},{"key":"2026090707075800400_cit24","first-page":"429","article-title":"Quantitative Analysis\nof Plasmodium berghei Liver Stages by Bioluminescence Imaging","volume-title":"Malaria Methods and Protocols","author":"Annoura","year":"2013"},{"issue":"4","key":"2026090707075800400_cit25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123473","article-title":"In Vivo and In Vitro Characterization of a Plasmodium\nLiver Stage-Specific Promoter","volume":"10","author":"De Niz","year":"2015","journal-title":"PLoS One"},{"key":"2026090707075800400_cit26","doi-asserted-by":"publisher","first-page":"1105655","DOI":"10.3389\/fimmu.2023.1105655","article-title":"Review: Current\ntrends, challenges,\nand success stories in adjuvant research","volume":"14","author":"Singleton","year":"2023","journal-title":"Frontiers\nin Immunology"},{"issue":"12","key":"2026090707075800400_cit27","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1128\/IAI.00923-13","article-title":"Toll-like receptor\n7 mediates early innate immune responses to malaria","volume":"81","author":"Baccarella","year":"2013","journal-title":"Infect. Immun."},{"issue":"11","key":"2026090707075800400_cit28","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202100144","article-title":"Virus-Mimic mRNA Vaccine\nfor Cancer Treatment","volume":"4","author":"Meng","year":"2021","journal-title":"Advanced Therapeutics."},{"issue":"11","key":"2026090707075800400_cit29","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.4049\/jimmunol.1602131","article-title":"Cutting Edge: A Dual\nTLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated\nImmune Responses","volume":"198","author":"Gutjahr","year":"2017","journal-title":"Journal of Immunology."},{"issue":"4","key":"2026090707075800400_cit30","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70096","article-title":"Hepatocyte Toll-like receptors contribute to the hepcidin\ninflammatory response to pathogens and pathogen-derived ligands","volume":"9","author":"Bonitz","year":"2025","journal-title":"Hemasphere"},{"issue":"11","key":"2026090707075800400_cit31","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor\nsignaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"2026090707075800400_cit32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors\nand adaptor molecules in liver\ndisease: update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology."},{"issue":"1","key":"2026090707075800400_cit33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/14760584.2017.1256208","article-title":"A potent\nadjuvant effect of a CD1d-binding NKT cell\nligand in human immune system mice","volume":"16","author":"Li","year":"2017","journal-title":"Expert Review\nof Vaccines."},{"issue":"6","key":"2026090707075800400_cit34","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.4049\/jimmunol.1403017","article-title":"Colocalization of a CD1d-Binding Glycolipid with a\nRadiation-Attenuated Sporozoite Vaccine in Lymph Node\u2013Resident\nDendritic Cells for a Robust Adjuvant Effect","volume":"195","author":"Li","year":"2015","journal-title":"Journal of Immunology."},{"issue":"1","key":"2026090707075800400_cit35","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1038\/s41598-024-53118-9","article-title":"Ultra-low\nvolume intradermal administration of radiation-attenuated\nsporozoites with the glycolipid adjuvant 7DW8\u20135 completely\nprotects mice against malaria","volume":"14","author":"Watson","year":"2024","journal-title":"Scientific Reports."},{"key":"2026090707075800400_cit36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fcimb.2018.00247","article-title":"OX40 Stimulation Enhances\nProtective Immune Responses Induced After Vaccination With Attenuated\nMalaria Parasites","volume":"8","author":"Othman","year":"2018","journal-title":"Frontiers in Cellular and\nInfection Microbiology."},{"key":"2026090707075800400_cit37","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3389\/fimmu.2020.01377","article-title":"A Peptide-Based PD1 Antagonist Enhances T-Cell\nPriming and Efficacy of a Prophylactic Malaria Vaccine and Promotes\nSurvival in a Lethal Malaria Model","volume":"11","author":"Phares","year":"2020","journal-title":"Front Immunol."},{"issue":"1","key":"2026090707075800400_cit38","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1038\/s41467-019-11819-0","article-title":"Innate\nimmunity\nlimits protective adaptive immune responses against pre-erythrocytic\nmalaria parasites","volume":"10","author":"Minkah","year":"2019","journal-title":"Nature Communications."},{"issue":"1","key":"2026090707075800400_cit39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42247-023-00453-8","article-title":"Implications\nof biomimetic nanocarriers in\ntargeted drug delivery","volume":"6","author":"Al-Hetty","year":"2023","journal-title":"Emergent Mater."},{"key":"2026090707075800400_cit40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120395","article-title":"Platelet membrane camouflaged nanoparticles: Biomimetic\narchitecture for targeted therapy","volume":"598","author":"Kunde","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"14","key":"2026090707075800400_cit41","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.3390\/nano12142485","article-title":"Biomimetic\nNanomaterials: Diversity,\nTechnology, and Biomedical Applications","volume":"12","author":"Gareev","year":"2022","journal-title":"Nanomaterials\n(Basel)"},{"issue":"10","key":"2026090707075800400_cit42","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.7150\/thno.33467","article-title":"A tracer-based method\nenables tracking of Plasmodium falciparum malaria parasites during\nhuman skin infection","volume":"9","author":"Winkel","year":"2019","journal-title":"Theranostics."},{"issue":"8","key":"2026090707075800400_cit43","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2967\/jnumed.123.266715","article-title":"hHEPATO-Cy5, a Bimodal\nTracer for Image-Guided Hepatobiliary Surgery","volume":"65","author":"Rietbergen","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"1","key":"2026090707075800400_cit44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12951-025-03258-5","article-title":"Mitochondria-targeted\nnanovesicles for ursodeoxycholic acid delivery\nto combat neurodegeneration by ameliorating mitochondrial dysfunction","volume":"23","author":"Zhang","year":"2025","journal-title":"Journal of Nanobiotechnology"},{"issue":"3","key":"2026090707075800400_cit45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1039\/D3CB00219E","article-title":"Engineered triphenylphosphonium-based,\nmitochondrial-targeted liposomal\ndrug delivery system facilitates cancer cell killing actions of chemotherapeutics","volume":"5","author":"Sivagnanam","year":"2024","journal-title":"RSC Chem. Biol."},{"issue":"2","key":"2026090707075800400_cit46","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10214","article-title":"Cell therapies\nin the clinic","volume":"6","author":"Wang","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"2026090707075800400_cit47","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jconrel.2021.07.047","article-title":"Biomimetic and cell-based\nnanocarriers - New strategies for brain tumor targeting","volume":"337","author":"Mendanha","year":"2021","journal-title":"J. Controlled Release"},{"key":"2026090707075800400_cit48","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2024.102540","article-title":"Enhanced efficacy of\nBCG vaccine\nformulated in adjuvant is dependent on IL-17A expression","volume":"148","author":"Derrick","year":"2024","journal-title":"Tuberculosis."},{"key":"2026090707075800400_cit49","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3389\/fimmu.2018.02510","article-title":"Early Induction of Human\nRegulatory Dermal\nAntigen Presenting Cells by Skin-Penetrating Schistosoma Mansoni Cercariae","volume":"9","author":"Winkel","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00575","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4719\/67247766\/acs.molpharmaceut.6c00575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4719\/67247766\/acs.molpharmaceut.6c00575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:10:22Z","timestamp":1788779422000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/9\/4719\/5313308\/The-Road-toward-a-Trojan-Horse-Malaria-Vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,23]]},"published-print":{"date-parts":[[2026,9,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00575","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,23]]}}}